These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11881861)
1. Topiramate: a new safe and effective antiepileptic. Gupta M; Rehman N; Bansal J; Mogre V J Indian Med Assoc; 2001 Aug; 99(8):449-50. PubMed ID: 11881861 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]
3. Topiramate slow dose titration: improved efficacy and tolerability. Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117 [TBL] [Abstract][Full Text] [Related]
4. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals. Giannakodimos ST; Georgiadis G; Tsounis ST; Triantafillou N; Kimiskidis V; Giatas K; Karlovasitou A; Mitsikostas DD; Thodi E; Polychronopoulos P; Ramopoulos N; Michailidis K; Michalis N; Garganis K; Gatzonis ST; Balogiannis ST; Kazis AR; Milonas J; Van Oene JC Seizure; 2005 Sep; 14(6):396-402. PubMed ID: 16019237 [TBL] [Abstract][Full Text] [Related]
5. Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial. Korian Topiramate Study Group Seizure; 2002 Jun; 11(4):255-60. PubMed ID: 12027573 [TBL] [Abstract][Full Text] [Related]
7. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Nieto-Barrera M; Candau R; Nieto-Jimenez M; Correa A; del Portal LR Seizure; 2000 Dec; 9(8):590-4. PubMed ID: 11162758 [TBL] [Abstract][Full Text] [Related]
8. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group. Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J; Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ; Kelly K; Parker P; Brodie MJ Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [TBL] [Abstract][Full Text] [Related]
11. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study. Cho YJ; Heo K; Kim WJ; Jang SH; Jung YH; Ye BS; Song DB; Lee BI Epilepsia; 2009 Aug; 50(8):1910-9. PubMed ID: 19563348 [TBL] [Abstract][Full Text] [Related]
14. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study. Baker GA; Currie NG; Light MJ; Schneiderman JH; Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254 [TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial. Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628 [TBL] [Abstract][Full Text] [Related]
16. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy. Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B; Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865 [TBL] [Abstract][Full Text] [Related]
17. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
18. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083 [TBL] [Abstract][Full Text] [Related]
20. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]